Guardant Health (GH) director converts 155 RSUs into common shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Guardant Health director Steve E. Krognes reported an exercise of restricted stock units that delivered 155 shares of common stock on June 30, 2026. These RSUs were from an award granted on August 9, 2022, which vested 25% on June 30, 2023 and the remaining 75% over the following three years.

After this derivative exercise, Krognes directly holds 14,580 shares of Guardant Health common stock. This Form 4 reflects a compensation-related vesting and conversion of equity awards, with no open-market buying or selling reported in this filing.

Insider Trade Summary

155 shares exercised/converted

Mixed 2 txns

Insider Krognes Steve E.

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	155	$0.00	--
Exercise	Common Stock	155	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 14,580 shares (Direct, null)

Footnotes (1)

This represents a restricted stock unit award granted on August 9, 2022. 25% of the shares subject to such award vested on June 30, 2023 and the remaining 75% of the shares subject to such award vested during the three-year period thereafter. Not applicable for Restricted Stock Units.

Key Figures

RSUs converted: 155 shares Exercise price: $0.00 per share Shares held after transaction: 14,580 shares +1 more

4 metrics

RSUs converted 155 shares Restricted Stock Units converted to common stock on June 30, 2026

Exercise price $0.00 per share Conversion of restricted stock units to common stock

Shares held after transaction 14,580 shares Director’s direct common stock holdings following the June 30, 2026 conversion

Remaining RSUs from this award 0 units Restricted stock unit award granted August 9, 2022 now fully vested

Key Terms

Restricted Stock Units, restricted stock unit award, vested

3 terms

Restricted Stock Units financial

"This represents a restricted stock unit award granted on August 9, 2022."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

restricted stock unit award financial

"This represents a restricted stock unit award granted on August 9, 2022."

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

vested financial

"25% of the shares subject to such award vested on June 30, 2023 and the remaining 75% of the shares subject to such award vested during the three-year period thereafter."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 06:08 PM Accepted by SEC EDGAR 07/02/2026 - 06:07 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Krognes Steve E.

(Last)

(First)

(Middle)

3100 HANOVER STREET

(Street)

PALO ALTO

CALIFORNIA

94304

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/30/2026		M		155	A	$0	14,580	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	$0	06/30/2026		M			155	⁽¹⁾	⁽²⁾	Common Stock	155	$0	0	D

Explanation of Responses:

1. This represents a restricted stock unit award granted on August 9, 2022. 25% of the shares subject to such award vested on June 30, 2023 and the remaining 75% of the shares subject to such award vested during the three-year period thereafter.

2. Not applicable for Restricted Stock Units.

Remarks:

	/s/ John Saia, as attorney-in-fact for Steve Krognes	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Guardant Health (GH) report for Steve E. Krognes?

Guardant Health director Steve E. Krognes exercised restricted stock units into 155 shares of common stock. The transaction reflects equity compensation vesting, not an open-market purchase or sale, and was reported on a Form 4 as a derivative exercise/conversion event.

How many Guardant Health shares does Steve E. Krognes hold after this Form 4?

Following the RSU conversion, Steve E. Krognes directly holds 14,580 shares of Guardant Health common stock. This total reflects his position after receiving 155 shares from the vested restricted stock unit award reported in the June 30, 2026 transaction.

Was the Guardant Health (GH) Form 4 a stock buy or sell by Steve E. Krognes?

The Form 4 does not show a buy or sell; it reports a derivative exercise. Restricted stock units converted into 155 common shares at a zero exercise price, reflecting routine equity compensation vesting rather than an open-market trade by the director.

What is the source of the 155 shares reported for Steve E. Krognes at Guardant Health?

The 155 shares came from a restricted stock unit award granted on August 9, 2022. According to the footnotes, 25% vested on June 30, 2023, and the remaining 75% vested over the following three-year period, culminating in this June 30, 2026 conversion.

Does Steve E. Krognes have any remaining restricted stock units after this Guardant Health transaction?

After this transaction, the reported restricted stock unit position shows zero units remaining. The Form 4 indicates 155 RSUs were converted into 155 common shares, completing this particular award’s vesting and leaving no RSUs from that grant outstanding.